In-vivo evaluation of tissue scaffolds containing simvastatin loaded nanostructured lipid carriers and mesenchymal stem cells in diabetic wound healing

被引:18
|
作者
Orgul, Dilara [1 ]
Eroglu, Hakan [1 ]
Tiryaki, Meral [2 ]
Pinarli, Ferda Alpaslan [2 ]
Hekimoglu, Sueda [1 ]
机构
[1] Hacettepe Univ, Fac Pharm, Dept Pharmaceut Technol, Ankara, Turkey
[2] Diskapi Yildirim Beyazit Training & Res Hosp, Cell Res & Genet Diag Ctr, Ankara, Turkey
关键词
Simvastatin; Nanostructured lipid carriers; Tissue scaffold; Wound healing; Stem cells; ENDOTHELIAL PROGENITOR CELLS; CHITOSAN SCAFFOLDS; ANGIOGENESIS; STATINS; GROWTH; SKIN; NANOPARTICLES; DELIVERY; DESIGN; PHARMACOKINETICS;
D O I
10.1016/j.jddst.2020.102140
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Efficacy of simvastatin on wound healing and stem cell treatment, in addition to the cholesterol lowering mechanism, has been investigated in recent studies. In this study we have focused on formulation of tissue scaffolds comprised of mesenchymal stem cells and simvastatin loaded nanostructured lipid carriers (NLCs) dispersed in a polymeric matrix. These three dimensional and biodegradable systems were designed to bring a new perspective in treatment of diabetic wound. Therefore, NLC formulations containing simvastatin at the concentrations of 10% or 20% of lipid phase were prepared by high pressure homogenization technique. Simvastatin loaded NLC formulations were characterized with mean particle size of 158.15 +/- 1.229 nm, PDI values lower than 0.17 and encapsulation efficiency above 99%. In-vitro release studies of simvastatin loaded NLC formulations were characterized by a high burst-release followed by sustained up to 12-24 h. Tissue scaffold formulations containing simvastatin loaded NLCs were prepared by freeze drying method. Cross-linked tissue scaffold formulations were prepared with 2:1 chitosan:collagen polymer ratio and 2-fold concentrated NLC formulation, having a three-dimensional structure with porosity value of 74.38%, pore size distribution within 20-200 mu m, 710.88% high water absorption capacity, 57.7% weight loss and suitable mechanical strength for in-vivo studies. Incorporation of NLCs into tissue scaffolds decreased the initial simvastatin burst release ratio and provided controlled release profile. Tissue scaffolds containing simvastatin lipid nanoparticles increased wound closure rate, promoted vascularization of injured tissue and enhanced viability and proliferation of stem cells. Thereupon, tissue scaffold formulation containing simvastatin lipid nanoparticles and stem cells together provided effective wound healing with increased epithelialization, proliferation and vascularization.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Formulation and characterization of tissue scaffolds containing simvastatin loaded nanostructured lipid carriers for treatment of diabetic wounds
    Orgul, Dilara
    Eroglu, Hakan
    Hekimoglu, Sueda
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2017, 41 : 280 - 292
  • [2] In vivo evaluation of a simvastatin-loaded nanostructured lipid carrier for bone tissue regeneration
    Yue, Xinxin
    Niu, Mao
    Zhang, Te
    Wang, Cheng
    Wang, Zhonglei
    Wu, Wangxi
    Zhang, Qi
    Lai, Chunhua
    Zhou, Lei
    NANOTECHNOLOGY, 2016, 27 (11)
  • [3] Simvastatin and adenosine-co-loaded nanostructured lipid carriers for wound healing: Development, characterization and cell-based investigation
    Dare, Regina Gomes
    Costa, Ana Beatriz Chieco
    Martins, Tereza Silva
    Lopes, Luciana B.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2024, 205
  • [4] Simvastatin Nanoparticles Loaded Polymeric Film as a Potential Strategy for Diabetic Wound Healing: In Vitro and In Vivo Evaluation
    Tufail, Saima
    Siddique, Muhammad Irfan
    Sarfraz, Muhammad
    Sohail, Muhammad Farhan
    Shahid, Muhammad Nabeel
    Omer, Muhammad Ovais
    Katas, Haliza
    Rasool, Fatima
    CURRENT DRUG DELIVERY, 2022, 19 (05) : 534 - 546
  • [5] Simvastatin-Loaded Nanostructured Lipid Carriers as Topical Drug Delivery System for Wound Healing Purposes: Preparation, Characterization, and In Vivo Histopathological Studies
    Mousavi-Simakani, Seyedeh Maryam
    Azadi, Amir
    Tanideh, Nader
    Omidifar, Navid
    Ghasemiyeh, Parisa
    Mohammadi-Samani, Soliman
    ADVANCED PHARMACEUTICAL BULLETIN, 2023, 13 (04) : 761 - 771
  • [6] Mesenchymal stem cells associated with chitosan scaffolds loaded with rosuvastatin to improve wound healing
    Maged, Amr
    Abdelkhalek, Abdelfattah A.
    Mahmoud, Azza A.
    Salah, Salwa
    Ammar, Mohamed M.
    Ghorab, Mahmoud M.
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 127 : 185 - 198
  • [7] In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers
    Jia, Lejiao
    Shen, Jingyi
    Zhang, Dianrui
    Duan, Cunxian
    Liu, Guangpu
    Zheng, Dandan
    Tian, Xiaona
    Liu, Yue
    Zhang, Qiang
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2012, 50 (03) : 523 - 529
  • [8] Provesicular elastic carriers of Simvastatin for enhanced wound healing activity: An in-vitro/in-vivo study
    Abd El-Alim, Sameh Hosam
    Salama, Abeer
    Darwish, Asmaa Badawy
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2020, 585
  • [9] Formulation, optimization, and in-vivo evaluation of nanostructured lipid carriers loaded with Fexofenadine HCL for oral delivery
    Abdelhameed, Asmaa H.
    Abdelhafez, Wael A.
    Saleh, Kh, I
    Mohamed, Mohamed S.
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2022, 74
  • [10] Formulation, Optimization, In-Vitro and In-Vivo Evaluation of Nateglinide-Loaded Nanostructured Lipid Carriers for Enhanced Bioavailability
    Tiwari, Shradha S.
    Dange, Yuvraj D.
    Honmane, Sandip M.
    Saralaya, Mahesh G.
    Gattani, Surendra G.
    Wadher, Shailesh J.
    Sarda, Rohit R.
    Mahaparale, Paresh R.
    BIONANOSCIENCE, 2025, 15 (01)